News

ImmunoCellular said ICT-107 is its lead dendritic cell (DC) based vaccine for the treatment of glioblastoma multiforme (GBM). The company in collaboration with its partners has developed the

Ranbaxy Morocco has been authorized by the Moroccan Health Authorities to commence manufacturing of its products at its Casablanca facility. With this new facility, Ranbaxy is expected to

Esmya is a first-in-class, orally active selective progesterone receptor modulator which reversibly blocks progesterone receptors in target tissues. The multi-center randomized double-blind US Phase 3 study included 300

HDS owns and markets Clotamin, an OTC multivitamin product designed exclusively for use by patients on Warfarin and other anticoagulants (blood thinners). Sunpeaks CEO Mackie Barch said as

Following merger, LTS Nutraceuticals will be renamed as LTS International. The proposed merger will result in cost savings and efficiencies allowing LTS Nutraceuticals to continue its plan for

Naratriptan is a generic equivalent form of GlaxoSmithKline’s Naramig (Naratriptan Hydrochloride), indicated in the acute treatment of the headache phase of migraine attacks with or without aura. Teva

The patent covers the process of treating live plant material in a CRS hydrodynamic process to increase absorption by the body and to efficiently transport and release the

CB-03-01 acts by blocking testosterone (T) and dihydrotestosterone (DHT) from binding to the receptor in the cell. The multi-center double-blind placebo controlled dose-escalating Phase II acne study will

Domainex’s Combinatorial Domain Hunting (CDH) technology is used to identify a form of the MEK protein which can be produced in large quantities and is suitable for structure-based